Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion

Author:

Venekamp Roderick P1,Javed Faisal2,van Dongen Thijs MA1,Waddell Angus3,Schilder Anne GM4

Affiliation:

1. University Medical Center Utrecht; Julius Center for Health Sciences and Primary Care & Department of Otorhinolaryngology; Heidelberglaan 100 Utrecht Netherlands 3508 GA

2. Bristol University Hospitals; ENT Department; Bristol UK

3. Great Western Hospital; ENT Department; Marlborough Road Swindon UK SN3 6BB

4. Faculty of Brain Sciences, University College London; evidENT, Ear Institute; 330 Grays Inn Road London UK WC1X 8DA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference44 articles.

1. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes;Dohar;Pediatrics,2006

2. Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes;Goldblatt;International Journal of Pediatric Otorhinolaryngology,1998

3. Topical ciprofloxocin is superior to topical saline and systemic antibiotics in the treatment of tympanostomy tube otorrhea in children: the results of a randomized clinical trial;Heslop;Laryngoscope,2010

4. A multicenter, randomized, double-blind clinical trial to assess the efficacy and safety of ciprofloxacin 0.3% plus fluocinolone acetonide 0.025% otic solution compared to ciprofloxacin 0.3% otic solution and to fluocinolone acetonide 0.025% otic solution in the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023239-40/results (accessed 18 April 2016)

5. NCT01404611. A multicenter, randomized, double-blind clinical trial to assess the efficacy and safety of DF289 plus DF277 otic solution compared to DF289 otic solution and to DF277 otic solution in the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients https://clinicaltrials.gov/show/NCT01404611 (accessed 18 April 2016)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3